Exploring how asymptomatic Plasmodium falciparum infections in African infants form a hidden reservoir that sustains malaria transmission, revealed through multilocus genotyping.
Discover how the unique enzyme Ap4A hydrolase in malaria parasites presents a promising new drug target for combating drug-resistant malaria.
Discover how Plasmodium falciparum, the malaria parasite, utilizes erythrocytic adenosine monophosphate as an alternative purine source for survival and replication.
A comparative analysis of three anti-malaria drug combinations tested in Senegal to determine the most effective treatment for uncomplicated Plasmodium falciparum malaria.
Discover how scientists are using cutting-edge molecular techniques to distinguish Plasmodium falciparum populations for improved malaria treatment and clinical research.